Xinyu Li
CIK: 0002123500
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BYAH
Park Ha Biological Technology Co., Ltd.
Officer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Li Xinyu
Li Xinyu (SEC CIK 0002123500) files insider reports with the SEC as CTO of Park Ha Biological Technology Co., Ltd. (BYAH).
Signal8 holds 1 ownership filing by Li Xinyu, a Form 3, filed on Apr 7, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Li Xinyu's filings is in SHANGHAI.
Other insiders filing for Park Ha Biological Technology Co., Ltd. (BYAH)
- Wang Li (Alya), COO
- Zhu Xiaoyan, CFO
- Shan Yanan, Director
- Yu Xiaozhong, Director
- Zhang Xiaoqiu, CEO
- Sheng Qixiong, Director